[
  {
    "ts": "2025-08-18T14:00:00+00:00",
    "headline": "Global Ophthalmology Drugs Market to Reach USD 26.28 Billion by 2030 | MarketsandMarkets™",
    "summary": "Delray Beach, FL, Aug. 18, 2025 (GLOBE NEWSWIRE) -- North America leads market expansion as companies advance next-generation ophthalmic therapies to address rising prevalence of vision-threatening diseasesThe global ophthalmology drugs market, valued at US$18.34 billion in 2024, stood at US$19.52 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$26.28 billion by the end of the period. This growth trajectory ref",
    "url": "https://finance.yahoo.com/news/global-ophthalmology-drugs-market-reach-140000556.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "42eacbea-fd89-32c2-8f9a-9cf56dcbbb35",
      "content": {
        "id": "42eacbea-fd89-32c2-8f9a-9cf56dcbbb35",
        "contentType": "STORY",
        "title": "Global Ophthalmology Drugs Market to Reach USD 26.28 Billion by 2030 | MarketsandMarkets™",
        "description": "",
        "summary": "Delray Beach, FL, Aug. 18, 2025 (GLOBE NEWSWIRE) -- North America leads market expansion as companies advance next-generation ophthalmic therapies to address rising prevalence of vision-threatening diseasesThe global ophthalmology drugs market, valued at US$18.34 billion in 2024, stood at US$19.52 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$26.28 billion by the end of the period. This growth trajectory ref",
        "pubDate": "2025-08-18T14:00:00Z",
        "displayTime": "2025-08-18T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/d4c3eb630bf83da5a3947696840b275d",
          "originalWidth": 669,
          "originalHeight": 229,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gJGmrgIEhQHgqRhQWU0iFg--~B/aD0yMjk7dz02Njk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d4c3eb630bf83da5a3947696840b275d.cf.webp",
              "width": 669,
              "height": 229,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KrbQ1ehrVFbVg5dwvncePQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d4c3eb630bf83da5a3947696840b275d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/global-ophthalmology-drugs-market-reach-140000556.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/global-ophthalmology-drugs-market-reach-140000556.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]